11β-HSD1抑制剂改善db/db小鼠胰岛素敏感性的实验研究
An 11β-HSD1 inhibitor improves insulin sensitivity in db/db mice

DOI: 10.6040/j.issn.1671-7554.0.2016.1379

Keywords: 11β-羟基类固醇脱氢酶1抑制剂,胰岛素抵抗,db/db小鼠,
Insulin resistance,db/db mouse,11β-HSD1 inhibitor

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Andrews RC, Rooyackers O, Walker BR. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes[J]. J Clin Endocrinol Metab, 2003, 88(1): 285-291.
[2]	Song A, Xu M, Bi Y, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults[J]. PLoS One, 2011, 6(4): e19228.
[3]	李涛, 傅继华, 王天莹. 糖皮质激素诱导胰岛素抵抗的研究进展[J]. 海峡药学, 2015, 27(5): 1-5. LI Tao, FU Jihua, WANG Tianying. Research progress on glucocorticoid-induced insulin resistance[J]. Strait Pharmaceutical Journal, 2015, 27(5):1-5.
[4]	阮莉莉, 邹朝春. 11β-羟基类固醇脱氢酶与代谢综合征的相关性[J]. 上海交通大学学报(医学版), 2014, 34(6): 924-928. RUAN Lili, ZOU Chaochun. Correlation between 11β-hydroxysteroid dehydrogenase and metabolic syndrome[J]. Journal of Shanghai Jiaotong University Medical Science, 2014, 34(6): 924-928.
[5]	陈玉鹏, 黄芳. 中药活性成分治疗糖尿病胰岛素抵抗的机制研究进展[J]. 药学进展, 2016, 40(3): 197-204. CHEN Yupeng, HUANG fang. Research progress on the mechanisms of active ingredients from traditional chinese medicines in treatment of diabetic insulin resistance[J]. Prog Pharm Sci, 2016, 40(3): 197-204.
[6]	Morgan SA, McCabe EL, Gathercole LL, et al. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess[J]. Proc Natl Acad Sci U S A, 2014, 111(24): E2482-2491.
[7]	刘永贵,解学星,吴疆,等. 治疗2型糖尿病的新靶点药物研究进展[J].现代药物与临床, 2015, 30(2): 222-227. LIU Yongkui, XIE Xuexing, WU Jiang, et al. Research progress on drugs with new targets in treatment of type 2 diabetes[J]. Drugs & Clinic, 2015, 30(2): 222-227.
[8]	Byun SY, Shin YJ, Nam KY, et al. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499[J]. Life Sci, 2015, 120: 1-7.
[9]	Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases[J]. JPEN J Parenter Enteral Nutr, 2006, 30(1): 45-51.
[10]	裴蕾蕾, 孙中华, 李哲, 等. 西格列汀联合大剂量胰岛素治疗2型糖尿病的临床观察[J]. 山东大学学报(医学版), 2015, 53(2): 39-42. PEI Leilei, SUN Zhonghua, LI Zhe, et al. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus[J]. Journal of Shandong University(Health Sciences), 2015, 53(2): 39-42.
[11]	Rahimi-Madiseh M, Heidarian E, Kheiri S, et al. Effect of hydroalcoholic Allium ampeloprasum extract on oxidative stress, diabetes mellitus and dyslipidemia in alloxan-induced diabetic rats[J]. Biomed Pharmacother, 2017, 86: 363-367.
[12]	Morgan SA, Sherlock M, Gathercole LL, et al. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle[J]. Diabetes, 2009, 58(11): 2506-2515.
[13]	Oh H, Jeong KH, Han HY, et al. A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models[J]. Eur J Pharmacol, 2015, 768: 139-148.
[14]	Okazaki S, Takahashi T, Iwamura T, et al. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models[J]. J Pharmacol Exp Ther, 2014, 351(1): 181-189.
[15]	Paterson JM, Morton NM, Fievet C, et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice[J]. Proc Natl Acad Sci U S A, 2004, 101(18): 7088-7093.
[16]	Anderson A, Walker BR. 11β-HSD1 inhibitors for the treatment of type 2diabetes and cardiovascular disease[J]. Drugs, 2013, 73(13): 1385-1393.
[17]	Yuan X, Li H, Bai H, et al. Synthesis of novel curcumin analogues for inhibition of 11beta-hydroxysteroid dehydrogenase type 1 with anti-diabetic properties[J]. Eur J Med Chem, 2014, 77: 223-230.
[18]	Stulnig TM, Waldh？usl W. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes[J]. Diabetologia, 2004, 47(1): 1-11.
[19]	da Rocha Junior LF, Rêgo MJ, Cavalcanti MB, et al. Synthesis of a novel thiazolidinedione and evaluation of its modulatory effect on IFN- γ, IL-6, IL-17A, and IL-22 production in PBMCs from rheumatoid arthritis patients[J]. Biomed Res Int, 2013: 926060.
[20]	崔同军, 叶磊, 辛婧. 11β-羟基类固醇脱氢酶通过改变糖皮质激素活性参与机体多个病理环节[J]. 医学综述, 2013, 19(1): 40-42. CUI Tongjun, YE Lei, XIN jing. 11β-HSD involved in pathological link through the conversion of glucocorticoid[J]. Medical Recapitulate, 2013, 19(1):40-42.

Full-Text